Literature DB >> 28196762

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota.

Amanda J McFarlane1, Henry J McSorley1, Donald J Davidson2, Paul M Fitch1, Claire Errington3, Karen J Mackenzie2, Eva S Gollwitzer4, Chris J C Johnston5, Andrew S MacDonald6, Michael R Edwards7, Nicola L Harris8, Benjamin J Marsland4, Rick M Maizels5, Jürgen Schwarze9.   

Abstract

BACKGROUND: Helminth parasites have been reported to have beneficial immunomodulatory effects in patients with allergic and autoimmune conditions and detrimental consequences in patients with tuberculosis and some viral infections. Their role in coinfection with respiratory viruses is not clear.
OBJECTIVE: Here we investigated the effects of strictly enteric helminth infection with Heligmosomoides polygyrus on respiratory syncytial virus (RSV) infection in a mouse model.
METHODS: A murine helminth/RSV coinfection model was developed. Mice were infected by means of oral gavage with 200 stage 3 H polygyrus larvae. Ten days later, mice were infected intranasally with either RSV or UV-inactivated RSV.
RESULTS: H polygyrus-infected mice showed significantly less disease and pulmonary inflammation after RSV infection associated with reduced viral load. Adaptive immune responses, including TH2 responses, were not essential because protection against RSV was maintained in Rag1-/- and Il4rα-/- mice. Importantly, H polygyrus infection upregulated expression of type I interferons and interferon-stimulated genes in both the duodenum and lung, and its protective effects were lost in both Ifnar1-/- and germ-free mice, revealing essential roles for type I interferon signaling and microbiota in H polygyrus-induced protection against RSV.
CONCLUSION: These data demonstrate that a strictly enteric helminth infection can have remote protective antiviral effects in the lung through induction of a microbiota-dependent type I interferon response.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heligmosomoides polygyrus; Respiratory syncytial virus; helminths; microbiome; type I interferon

Mesh:

Substances:

Year:  2017        PMID: 28196762      PMCID: PMC6485385          DOI: 10.1016/j.jaci.2017.01.016

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  67 in total

1.  Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology.

Authors:  De'Broski R Herbert; Christoph Hölscher; Markus Mohrs; Berenice Arendse; Anita Schwegmann; Magda Radwanska; Mosiuoa Leeto; Richard Kirsch; Pauline Hall; Horst Mossmann; Björn Claussen; Irmgard Förster; Frank Brombacher
Journal:  Immunity       Date:  2004-05       Impact factor: 31.745

Review 2.  Viruses in asthma exacerbations.

Authors:  Wan C Tan
Journal:  Curr Opin Pulm Med       Date:  2005-01       Impact factor: 3.155

3.  Innate antimicrobial peptide protects the skin from invasive bacterial infection.

Authors:  V Nizet; T Ohtake; X Lauth; J Trowbridge; J Rudisill; R A Dorschner; V Pestonjamasp; J Piraino; K Huttner; R L Gallo
Journal:  Nature       Date:  2001-11-22       Impact factor: 49.962

4.  2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells.

Authors:  Aruna K Behera; Mukesh Kumar; Richard F Lockey; Shyam S Mohapatra
Journal:  J Biol Chem       Date:  2002-04-29       Impact factor: 5.157

5.  Respiratory syncytial virus infection in elderly and high-risk adults.

Authors:  Ann R Falsey; Patricia A Hennessey; Maria A Formica; Christopher Cox; Edward E Walsh
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

Review 6.  Immune responses and disease enhancement during respiratory syncytial virus infection.

Authors:  Peter J M Openshaw; John S Tregoning
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

7.  Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense.

Authors:  Douglas W Leaman; Frank J Longano; James R Okicki; Kenneth F Soike; Paul F Torrence; Robert H Silverman; Hagen Cramer
Journal:  Virology       Date:  2002-01-05       Impact factor: 3.616

8.  Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells.

Authors:  Ezra Aksoy; Claudia S Zouain; François Vanhoutte; Josette Fontaine; Norman Pavelka; Nathalie Thieblemont; Fabienne Willems; Paola Ricciardi-Castagnoli; Michel Goldman; Monique Capron; Bernard Ryffel; François Trottein
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

9.  Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children.

Authors:  Rosalyn J Singleton; Greg J Redding; Toby C Lewis; Patricia Martinez; Lisa Bulkow; Barbara Morray; Helen Peters; James Gove; Carol Jones; David Stamey; Deborah F Talkington; Jeffrey DeMain; John T Bernert; Jay C Butler
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

10.  Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada.

Authors:  L Navas; E Wang; V de Carvalho; J Robinson
Journal:  J Pediatr       Date:  1992-09       Impact factor: 4.406

View more
  44 in total

Review 1.  The immunology of the allergy epidemic and the hygiene hypothesis.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Immunol       Date:  2017-09-19       Impact factor: 25.606

2.  Plasmacytoid Dendritic Cells Facilitate Th Cell Cytokine Responses throughout Schistosoma mansoni Infection.

Authors:  Lauren M Webb; Alexander T Phythian-Adams; Alice H Costain; Sheila L Brown; Rachel J Lundie; Josephine Forde-Thomas; Peter C Cook; Lucy H Jackson-Jones; Angela K Marley; Hermelijn H Smits; Karl F Hoffmann; Elia D Tait Wojno; Andrew S MacDonald
Journal:  Immunohorizons       Date:  2021-08-30

3.  The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type III interferon.

Authors:  Katrina R Grau; Shu Zhu; Stefan T Peterson; Emily W Helm; Drake Philip; Matthew Phillips; Abel Hernandez; Holly Turula; Philip Frasse; Vincent R Graziano; Craig B Wilen; Christiane E Wobus; Megan T Baldridge; Stephanie M Karst
Journal:  Nat Microbiol       Date:  2019-11-25       Impact factor: 17.745

4.  Transkingdom Interactions Important for the Pathogenesis of Human Viruses.

Authors:  Andrew Nishimoto; Nicholas Wohlgemuth; Jason Rosch; Stacey Schultz-Cherry; Valerie Cortez; Hannah M Rowe
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

5.  Emerging issues in COVID-19 vaccination in Tropical Areas: Impact of the Immune Response against Helminths in Endemic Areas.

Authors:  Leonor Chacin-Bonilla; Nathalie Chacón-Fonseca; Alfonso J Rodriguez-Morales
Journal:  Travel Med Infect Dis       Date:  2021-05-26       Impact factor: 6.211

6.  Intestinal tête-à-tête: helminths blunt immunity against flaviviruses.

Authors:  David E Place; Thirumala-Devi Kanneganti
Journal:  Cell Res       Date:  2021-07       Impact factor: 46.297

7.  Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axis.

Authors:  Pritesh Desai; Hana Janova; James P White; Glennys V Reynoso; Heather D Hickman; Megan T Baldridge; Joseph F Urban; Thaddeus S Stappenbeck; Larissa B Thackray; Michael S Diamond
Journal:  Cell       Date:  2021-02-25       Impact factor: 66.850

Review 8.  Distinct Effects of Type I and III Interferons on Enteric Viruses.

Authors:  Harshad Ingle; Stefan T Peterson; Megan T Baldridge
Journal:  Viruses       Date:  2018-01-20       Impact factor: 5.048

9.  Toll-Like Receptor 4, but Not Neutrophil Extracellular Traps, Promote IFN Type I Expression to Enhance Th2 Responses to Nippostrongylus brasiliensis.

Authors:  Christophe Pellefigues; Shiau-Choot Tang; Alfonso Schmidt; Ruby F White; Olivier Lamiable; Lisa M Connor; Christiane Ruedl; Jurek Dobrucki; Graham Le Gros; Franca Ronchese
Journal:  Front Immunol       Date:  2017-11-16       Impact factor: 7.561

10.  Preliminary Trichinella spiralis Infection Ameliorates Subsequent RSV Infection-Induced Inflammatory Response.

Authors:  Ki-Back Chu; Hae-Ahm Lee; Hae-Ji Kang; Eun-Kyung Moon; Fu-Shi Quan
Journal:  Cells       Date:  2020-05-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.